Search clinical trials for: acid Zoledronic

Total 24083 results

Novartis

Terminated

Maintaining Bone Strength in Men With Prostate Cancer

Prostate Cancer

United Kingdom
Novartis

Completed

Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma

Treatment of Bone Metastases

China
Shenzhen People's Hospital

Recruiting

Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture

Denosumab vs Zoledronate

China
Novartis Pharmaceuticals

Completed

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

Breast Cancer | Multiple Myeloma

United States
Novartis Pharmaceuticals

Withdrawn

The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA

Prosthetic Fixation After Cementless Total Hip Arthroplasty

China
Massachusetts General Hospital
Dana-Farber Cancer Institute

Completed

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Prostate Cancer | Bone Loss

United States
Novartis Pharmaceuticals

Completed

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Multiple Myeloma Bone Disease

United Kingdom, United States
Novartis

Completed

Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid

Breast Cancer With Metastatic Bone Disease

Turkey
Thomas Lund

Completed

Prolonged Protection From Bone Disease in Multiple Myeloma (Magnolia)

Multiple Myeloma

Denmark
Yonsei University

Unknown

Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke Patients

Stroke

Korea, Republic of
Novartis Pharmaceuticals

Completed

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

Osteoporosis

Australia, Canada, Russian Federation, Hungary, South Africa, United Kingdom
Halozyme Therapeutics

Completed

Pharmacokinetic, Safety and Tolerability Study of SC Administered Bisphosphonate With rHuPH20 vs Bisphosphonate Alone

Risk Factors for or a Diagnosis of Osteoporosis

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital; American Society...

Completed

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

Multiple Myeloma

United States
Novartis Pharmaceuticals

Completed

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Prostate Cancer With Bone Metastasis
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
Ottawa Hospital Research Institute

Active, not recruiting

Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL) (REaCT-ZOL)

Early-stage Breast Cancer

Canada
Novartis Pharmaceuticals

Completed

Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants (Z-MARK)

Multiple Myeloma

United States
Spanish Breast Cancer Research Group
Novartis

Terminated

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Breast Cancer | Neoplasm Metastasis

Spain
Carmen Gómez-Vaquero

Terminated

Zoledronic Acid in Rheumatoid Arthritis (AZAR)

Arthritis, Rheumatoid

Spain
The Cleveland Clinic
Novartis Pharmaceuticals

Completed

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Osteoporosis

United States
Leiden University Medical Center

Terminated

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) (HR-GCT)

Giant Cell Tumor of Bone | Osteoclastoma

Netherlands, Belgium
Washington University School of Medicine
Novartis Pharmaceuticals

Terminated

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Uterine Cervical Neoplasms

United States
University Health Network, Toronto

Completed

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC (SubDueP)

Metastatic Prostate Cancer | Bone Metastasis

Canada
Roswell Park Cancer Institute

Terminated

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Multiple Myeloma and Plasma Cell Neoplasm

United States
Novartis Pharmaceuticals

Completed

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis

Prostate Cancer Patients With Bone Metastasis
Royal Prince Alfred Hospital, Sydney, Australia
Novartis

Completed

The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

Liver Transplantation | Osteoporosis | Fractures

Australia
Hoffmann-La Roche

Terminated

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Pain | Neoplasm Metastasis | Bone Neoplasm

United States, Italy, Chile, Russian Federation, Hungary, United Kingdom, Poland, Guatemala, Germany, Mexico, Puerto Rico, Greece, Australia, Switzerland, Argentina, Panama
Sun Yat-sen University

Recruiting

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Hepatocellular Carcinoma

China
Daping Hospital and the Research Institute of Surgery...

Unknown

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Bone Metastasis
University Health Network, Toronto
Canadian Breast Cancer Foundation

Completed

Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect (SuBDuE)

Metastatic Breast Cancer With Bone Involvement

Canada
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Breast Cancer With Bone Metastasis

Italy
National Taiwan University Hospital

Recruiting

The Optimal Long Term Treatment Strategy of Anti-resorptive Medications---The Extension of Denosumab Sequential Therapy

Osteoporosis | Bone Mineral Density

Taiwan
Nantes University Hospital

Terminated

Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol) (DBMZol)

Bone Demineralization Lesions in the Injured Marrow

France
Novartis Pharmaceuticals
University of Athens

Completed

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Prostate Cancer

Greece
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)

Paget's Disease of Bone

China
Novartis Pharmaceuticals

Completed

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

Prostate Cancer

United States
University of Sao Paulo General Hospital
Novartis

Unknown

The Use of Zoledronic Acid to Complex Regional Pain Syndrome (Aclasta)

Complex Regional Pain Syndromes

Brazil
Tehran University of Medical Sciences
Novartis

Unknown

Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients

Bone Marrow Transplantation | Beta-Thalassemia

Iran, Islamic Republic of
Germans Trias i Pujol Hospital

Completed

Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort

HIV Infections

Spain
Novartis

Withdrawn

Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee

Osteonecrosis

Australia
Fudan University

Unknown

The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion

Bone Mineral Density | Bone Turnover Markers | Image Changes of Lumbar Fusion

China
The Cleveland Clinic
Novartis

Completed

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

Breast Cancer | Lung Cancer | Prostate Cancer | Bone Metastases
Daewoong Pharmaceutical Co. LTD.

Recruiting

Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

Osteoporosis

Korea, Republic of
Oslo University Hospital
Sykehuset Ostfold; Betanien Hospital

Terminated

Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial

Stress Fracture Foot | Stress Fracture Ankle

Norway
Spokane Joint Replacement Center

Completed

Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty

Osteoporosis
Bayside Health
Novartis

Completed

Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention

Osteopenia | Complications of Heart-lung Transplant | Other Complications of Lung Transplant
Soroka University Medical Center
Tel-Aviv Sourasky Medical Center

Completed

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole

Breast Cancer

Israel
Centre Leon Berard

Terminated

Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies (MOSCAR)

Metastatic Renal Cell Carcinoma

France
PETHEMA Foundation
Novartis; Dynamic Solutions

Completed

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse (AZABACHE)

Multiple Myeloma

Spain
Severance Hospital

Completed

Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors

Gastrointestinal Cancer | Bone Metastasis

Korea, Republic of

3

Subscribe